1. Home
  2. GLTO vs UUU Comparison

GLTO vs UUU Comparison

Compare GLTO & UUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLTO
  • UUU
  • Stock Information
  • Founded
  • GLTO 2011
  • UUU 1969
  • Country
  • GLTO Denmark
  • UUU United States
  • Employees
  • GLTO N/A
  • UUU N/A
  • Industry
  • GLTO Biotechnology: Pharmaceutical Preparations
  • UUU Electronic Components
  • Sector
  • GLTO Health Care
  • UUU Technology
  • Exchange
  • GLTO Nasdaq
  • UUU Nasdaq
  • Market Cap
  • GLTO 6.5M
  • UUU 5.4M
  • IPO Year
  • GLTO 2020
  • UUU N/A
  • Fundamental
  • Price
  • GLTO $3.97
  • UUU $1.82
  • Analyst Decision
  • GLTO Buy
  • UUU
  • Analyst Count
  • GLTO 1
  • UUU 0
  • Target Price
  • GLTO $10.00
  • UUU N/A
  • AVG Volume (30 Days)
  • GLTO 17.1K
  • UUU 31.7K
  • Earning Date
  • GLTO 04-28-2025
  • UUU 02-14-2025
  • Dividend Yield
  • GLTO N/A
  • UUU N/A
  • EPS Growth
  • GLTO N/A
  • UUU N/A
  • EPS
  • GLTO N/A
  • UUU N/A
  • Revenue
  • GLTO N/A
  • UUU $22,168,402.00
  • Revenue This Year
  • GLTO N/A
  • UUU N/A
  • Revenue Next Year
  • GLTO N/A
  • UUU N/A
  • P/E Ratio
  • GLTO N/A
  • UUU N/A
  • Revenue Growth
  • GLTO N/A
  • UUU 5.57
  • 52 Week Low
  • GLTO $3.76
  • UUU $1.11
  • 52 Week High
  • GLTO $21.05
  • UUU $2.47
  • Technical
  • Relative Strength Index (RSI)
  • GLTO 37.21
  • UUU 34.38
  • Support Level
  • GLTO $3.84
  • UUU $1.65
  • Resistance Level
  • GLTO $4.38
  • UUU $1.80
  • Average True Range (ATR)
  • GLTO 0.28
  • UUU 0.06
  • MACD
  • GLTO -0.02
  • UUU -0.01
  • Stochastic Oscillator
  • GLTO 23.15
  • UUU 47.50

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

About UUU Universal Security Instruments Inc.

Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.

Share on Social Networks: